- <![CDATA[Expanding ctDNA Applications to RCC and Germ Cell Tumors]]><![CDATA[Experts explain how ctDNA tracking in metastatic cancer guides therapy tweaks, flags relapse early, and where it fails in brain/peritoneal disease.]]>onclive · 2mo ago↗ source
- <![CDATA[RAPNO Criteria and MRI Assessment in PLGG: Recommendations vs. Real-World Practice]]><![CDATA[Learn how clinicians weigh symptoms, MRI changes and family goals to decide when a child’s tumor needs treatment—beyond simple size cutoffs.]]>onclive · 2mo ago↗ source
- <![CDATA[ctDNA in Metastatic Urothelial Carcinoma]]><![CDATA[Experts explain how ctDNA tracking in metastatic cancer helps tailor immunotherapy, spot relapse early, and guide dose breaks—plus key limitations.]]>onclive